Bhanji Muna (CIK 1846905) reported 10 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy ARDX (26,455 shares), Buy NTLA (9,200 shares), Buy ARDX (41,551 shares), Buy VCYT (9,321 shares), Sell VCYT (4,589 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | ARDELYX, INC. (ARDX) | Director | Buy | 26,455 | $0 |
| 2026-06-10 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 9,200 | $0 |
| 2025-06-23 | ARDELYX, INC. (ARDX) | Director | Buy | 41,551 | $0 |
| 2025-06-23 | VERACYTE, INC. (VCYT) | Director | Buy | 9,321 | $0 |
| 2025-06-17 | VERACYTE, INC. (VCYT) | Director | Sell | 4,589 | $122,389 |
| 2025-06-13 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 8,000 | $0 |
| 2025-05-15 | CYTOKINETICS INC (CYTK) | Director | Sell | 1,454 | $43,227 |
| 2025-05-14 | CYTOKINETICS INC (CYTK) | Director | Buy | 7,333 | $0 |
| 2025-05-01 | Intellia Therapeutics, Inc. (NTLA) | Director | Sell | 265 | $2,252 |
| 2025-01-31 | Intellia Therapeutics, Inc. (NTLA) | Director | Sell | 265 | $2,642 |
Source: SEC Form 4 filings · as of 2026-06-18